Autopsy report · NCT00159575
Metformin in Assisted Reproduction-MET-AR-study
Cause of deathSlow enrollment, also drug or device supply
“Slow patient recruitment and expiry of study medication(aug2009)”
Life of this trial
- Registered 6 months after it had already started.
- Ran for about 5 years 1 month before it stopped.
- 150 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Norwegian University of Science and Technology
- Sponsor type
- University, hospital or other
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Metformin / Placebo treatment for 4 months
- Participants
- 150
- Sites
- 2
- Countries
- Norway
Trials that died the same way
- Efficacy of Valproate in Peripheral Neuropathic Pain
“slow recruitment and treatments beyond expiry date” - Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
“study was stopped after enrolment of about 200 patients for slow recruitment” - Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide
“PharmaMar has decided to end this study due to the slow recruitment rate of the trial” - The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa
“Slow recruitment of patients” - A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma
“slow patient recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.